| Literature DB >> 17429701 |
Eric W P Bakker1, Arianne P Verhagen, Cees Lucas, Hans J C M F Koning, Bart W Koes.
Abstract
Prospective inception cohort. To assess the prognostic value of spinal mechanical load, assessed with the 24-hour schedule (24HS), in subjects with acute non-specific low back pain (ALBP) and to examine the influence of spinal mechanical load on the course of ALBP. In view of the characteristics of the natural course of ALBP, this should be viewed as a persistent condition in many patients rather that a benign self-limiting disease. Therefore, secondary prevention could be beneficial. Spinal mechanical load is a risk factor for ALBP and possibly a (modifiable) prognostic factor for persistent (i.e. recurrent and/or chronic) LBP. One hundred patients from primary care with ALBP were eligible for inclusion. At 6 months, 88 subjects completed the follow-up. For the follow-up assessment a research assistant, unaware of our interest in the prognostic factors, contacted the subjects by telephone. Questionnaires were completed focusing on changes in demographic data and on the course and current status of ALBP. Persistent LBP occurred in 60% subjects. After multivariate regression analysis smoking (harmful) and advanced age (protective) were associated with persistent LBP. Differences in 24HS scores at baseline and follow-up were univariate-related to persistent LBP. Spinal mechanical load, quantified with the 24HS, is not a prognostic factor for persistent LBP. Modification of spinal mechanical load in terms of 24HS scores could be beneficial for secondary prevention in patients with acute LBP.Entities:
Mesh:
Year: 2007 PMID: 17429701 PMCID: PMC2219644 DOI: 10.1007/s00586-007-0347-5
Source DB: PubMed Journal: Eur Spine J ISSN: 0940-6719 Impact factor: 3.134
Characteristics of the study population
| Prognostic factors | Baseline | Lost-to-follow-up | Follow-up |
|---|---|---|---|
| Male (%) | 52/97 (54) | 3/9 (33) | 49/88 (56) |
| Age, mean (minimum–maximum, SD) | 40.7 (15–82, 13.5) | 37.4 (26–56, 9.4) | 41 (15–82, 14) |
| Previous episode(s) LBP (%) | 70/97 (72) | 8/9 (88) | 58/88 (67) |
| Smoking (%) | 34/97 (35) | 5/9 (56) | 29/88 (33) |
| 24HS sum-scores, mean (SD) | 34.4 (8.2) | 32.5 (9.0) | 34.6 (8.1) |
| NHP sum-scores, mean (SD) range 0–87 | 2.88 (2.2) | 2.7 (1.7) | 2.87 (2.3) |
| ALBPSQ, median (IQR). Range 12–192 | 65 (42–84) | 84 (46–94) | 64 (42–78) |
| Unemployment (%) | 7/97 (7) | 1/9 (11) | 6/88 (7) |
| Job satisfaction, mean (SD) | 7.5 (2.5) | 7 (2.9) | 7.6 (2.5) |
| Pain NRS, median (minimum–maximum) range 0–10 | 6 (0–10) | 6 (0–10) | 5 (0–9) |
| Duration of symptoms in days, mean (SD) | 11.7 (6.7) | 11.3 (6.7) | 11.8 (6.7) |
| Pain radiating in one or both legs (%) | 35/97 (36) | 4/9 (44) | 31/88 (35) |
| Spinal movement, mean (SD) | 6.3 (2.2) | 6.1 (3.0) | 6.5 (2.2) |
| As for daily occupation or while at work: ‘sitting’ | 57 | 5 | 52 |
| As for daily occupation or while at work: ‘variable work’ | 27 | 2 | 25 |
| As for daily occupation or while at work: ‘heavy spinal loading’ | 7 | 1 | 6 |
| As for daily occupation or while at work: ‘other’ (‘missing’) | 3 (3) | (1) | 3 (2) |
Fig. 1Flow chart
Subjects’ care seeking for baseline and recurrent LBP
| Baseline LBP | Recurrent LBPa | |
|---|---|---|
| Consultation GP | Once 7 (8%), twice 3 (3%) | Once 8 (20%) |
| Referral or treatment GP | Neurology 1 (1%), orthopaedic 2 (2%), other (no-medical) 6 (7%) | Other (no-medical) 6 (15%), medication 1 (2%) |
| Other treatment | No treatment 59 (67%), physical therapy 14 (16%), manual therapy 6 (7%), other 5 (6%), missing 4 (5%) | No treatment 38 (93%), physical therapy 6 (15%), manual therapy 1 (2%), other 1 (2%), missing 4 (10%) |
a Total number of recurrent episodes (N = 37) and recurrent episodes lasting longer then 12 weeks (N = 4)
Results of regression analysis for ‘persistent LBP’, ‘recurrent LBP’ or ‘chronicity’
| Persistent LBP | Recurrent LBP | Chronicity | ||||
|---|---|---|---|---|---|---|
| Predictors | Exp B, univariate (95% CI) | Exp B, multivariate (95% CI) | Exp B, univariate (95% CI) | Exp B, multivariate (95% CI) | Exp B, univariate (95% CI) | Exp B, multivariate (95% CI) |
| 24HS sum-scores | 1.07* (0.99–1.15) | 1.05 (0.97–1.14) | 1.08 (0.97–1.17) | 1.08 (0.98–1.18) | 1.00 (0.93–1.09) | – |
| Gender | 1.61 (0.68–3.82) | – | 1.6 (0.68–3.70) | – | 1.13 (0.33–3.89) | – |
| Age | 0.97 (0.94–1.00) | 0.96* (0.93–0.99) | 0.97 (0.94–0.99) | 0.97 * (0.94–99) | 0.99 (0.96–1.04) | – |
| Previous episode(s) of LBP | 1.37 (0.55–3.37) | – | 1.11 (0.46–2.70) | – | 2.76 (0.56–13.50) | – |
| Smoking | 3.71 (1.32–10.41) | 4.41* (1.50–12.95) | 2.08 (0.84–5.16) | – | 2.30 (0.67–7.90) | – |
| NHP scores | 1.06 (0.87–1.29) | – | 1.11 (0.92–1.34) | – | 0.93 (0.70–1.23) | – |
| ALBSQ scores | 0.99 (0.97–1.01) | – | 0.99 (0.98–11.01) | – | 1.00 (0.97–1.03) | – |
| (Un-) employment | 2.04 (0.51–8.21) | – | 2.16 (0.50–9.24) | – | 1.3 (0.15–1.38) | – |
| Job satisfaction | 0.89 (0.75–1.08) | – | 0.92 (0.77–1.09) | – | 1.02 (0.79–1.31) | – |
| Pain intensity at consultation | 0.97 (0.80–1.18) | – | 0.98 (0.81–1.18) | – | 1.09 (0.82–1.46) | – |
| Duration of symptoms | 0.99 (0.94–1.06) | – | 1.00 (0.94–1.07) | – | 1.01 (0.92–1.11) | – |
| Radiating leg pain | 0.96 (0.84–1.09) | – | 0.97 (0.87–1.08) | – | 0.56 (0.14–2.24) | – |
| Restricted spinal movement | 0.89 (0.72–1.09) | – | 0.88 (0.72–1.08) | – | 1.02 (0.77–1.36) | – |
| Physical therapy | 2.04 (0.65–6.37) | – | 1.06 (0.38–3.01) | – | 3.24 (0.89–11.84) | |
– Variable not taken into multivariate analysis (P > 0.1)
* Variable statistically significant in multivariate analysis
Predictors for persistent LBP, recurrent LPB and chronicity expressed in exponent B (OR) with their 95% confidence interval, in univariate and multivariate analysis
24HS Mean sum-scores at baseline and six months follow-up
| 24HS Sum-score at | Persistent LBP | No-persistent LBP | Mean difference | |
|---|---|---|---|---|
| Baseline (SD) | 36.1 (3.5) | 32.6 (11.8) | 3.5 | 0.04* |
| Follow-up (SD) | 5.4 (14.2) | −5.8 (11) | 11.2 | <0.0001* |
| Change (SD) | 30.7 (13.7) | 38.3 (14.2) | 7.6 | 0.01* |
Mean difference statistically significant
Fig. 2Distribution of subjects’ 24HS sum-scores at baseline and follow-up